RT Journal Article
SR Electronic
T1 Evidence for a shared genetic contribution to loneliness and Borderline Personality Disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.16.23286984
DO 10.1101/2023.03.16.23286984
A1 Schulze, Anna
A1 Streit, Fabian
A1 Zillich, Lea
A1 Awasthi, Swapnil
A1 Hall, Alisha S M
A1 Jungkunz, Martin
A1 Kleindienst, Nikolaus
A1 Frank, Josef
A1 Schwarze, Cornelia E
A1 Dahmen, Norbert
A1 Schott, Björn H
A1 Nöthen, Markus
A1 Mobascher, Arian
A1 Rujescu, Dan
A1 Lieb, Klaus
A1 Roepke, Stefan
A1 Herpertz, Sabine C
A1 Schmahl, Christian
A1 Bohus, Martin
A1 Ripke, Stephan
A1 Rietschel, Marcella
A1 Lis, Stefanie
A1 Witt, Stephanie
YR 2023
UL http://medrxiv.org/content/early/2023/08/18/2023.03.16.23286984.abstract
AB Loneliness, influenced by genetic and environmental factors such as childhood maltreatment, is one aspect of interpersonal dysfunction in Borderline Personality Disorder (BPD). Numerous studies link loneliness and BPD and twin studies indicate a genetic contribution to this association. The aim of our study was to investigate whether genetic predisposition for loneliness and BPD risk overlap and whether genetic risk for loneliness contributes to higher loneliness reported by BPD patients, using genome-wide genotype data. We assessed the genetic correlation of genome-wide association studies (GWAS) of loneliness and BPD using linkage disequilibrium score regression and tested whether a polygenic score for loneliness (loneliness-PGS) was associated with case-control status in two independent genotyped samples of BPD patients and healthy controls (HC; Witt2017-sample: 998 BPD, 1545 HC; KFO-sample: 187 BPD, 261 HC). In the KFO-sample, we examined associations of loneliness-PGS with reported loneliness, and whether the loneliness-PGS influenced the association between childhood maltreatment and loneliness. We found a genetic correlation between the GWAS of loneliness and BPD in the Witt2017-sample (rg = .23, p = .015), a positive association of loneliness–PGS with BPD case-control status (Witt2017-sample: NkR² = 2.3%, p = 2.7*10-12; KFO-sample: NkR² = 6.6%, p = 4.4*10-6), and a positive association between loneliness-PGS and loneliness across patient and control groups in the KFO-sample (β = .185, p = .002). The loneliness-PGS did not moderate the association between childhood maltreatment and loneliness in BPD. Our study is the first to use genome-wide genotype data to show that the genetic factors underlying variation in loneliness in the general population and the risk for BPD overlap. The loneliness-PGS was associated with reported loneliness. Further research is needed to investigate which genetic mechanisms and pathways are involved in this association and whether a genetic predisposition for loneliness contributes to BPD risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the German Research Foundation (KFO-256 and GRK2350/3 - 324164820).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committees of the medical faculty Mannheim of Heidelberg University, medical faculty Ludwig-Maximilians University, Landesaerztekammer Rheinland-Pfalz and Charite Berlin gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets presented in this article are not readily available because according to European law (GDPR), data containing potentially identifying or sensitive patient information are restricted; our data involving clinical participants are not freely available in the article, Supplementary Material, or in a public repository. Data are available upon reasonable request to the authors.